Clinical Trial Update: Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing contrast agents for liver MRI to detect hepatic metastases was terminated. Sponsor is University of Colorado, Denver, involving condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases
• Oligometastatic Disease

Snippet

Sponsor: University of Colorado, Denver | Conditions: Oligometastatic Disease, Liver Metastases | Phase 4 | Status: TERMINATED